company score funding investors employees industries biz model city contact
PragmatIC Semiconductor

Silicon-free chip maker.

46
$228M · Series D Latitude, UK Infrastructure Bank, MVolution Partners 101 to 250 Manufacturing, Semiconductor B2B Cambridge, UK •••••••••••@pragmaticsemi.com
NeoPhore

Small molecule neoantigen immuno-oncology therapies developer.

42
$12M · Series B Sixth Element Capital, 3B Future Health Fund, Astellas Venture Management 1 to 10 Health Tech Cambridge, UK •••••••••••@neophore.com
ViaNautis

Drug delivery platform.

42
$24M · Series A 4BIO Capital, UCB Ventures, Business Growth Fund 1 to 10 Health Tech, Biotech Cambridge, UK •••••••••••@vianautis.com
Sano Genetics

AI platform to advance precision medicine clinical trials.

42
$11M · Series A Seedcamp, Plural, Episode 1 11 to 50 Health Tech, Biotech B2B, SaaS Cambridge, UK •••••••••••@sanogenetics.com
CMR Surgical

Surgical robotic system for minimal access surgery.

42
$164M · Series D SoftBank Group, Tencent, ABB Technology Ventures 501 to 1000 Health Tech, Robotics B2B Cambridge, UK •••••••••••@cmrsurgical.com
Theia InsightsJUST ADDED

AI-powered investment analytics platform.

42
$6M · Series A Fidelity International Strategic Ventures, Unusual Ventures, Clocktower Technology Ventures 1 to 10 AI, Investing B2B, SaaS Cambridge, UK •••••••••••@theiainsights.com
Harness Therapeutics

Physiological upregulation therapy to treat neurodegenerative diseases.

37
$5M · Seed SV Health Investors 11 to 50 Health Tech, Biotech Cambridge, UK •••••••••••@harnesstx.com
Microbiotica

Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers.

37
$66M Seventure Partners, Cambridge Innovation Capital 11 to 50 Health Tech, Biotech, Deep Tech, Manufacturing B2B Cambridge, UK •••••••••••@microbiotica.com
ieso

Transforming mental healthcare by unlocking the power of clinical data

37
$52M · Series B Molten Ventures 101 to 250 Health Tech, Deep Tech B2B, B2C Cambridge, UK •••••••••••@iesogroup.com
Uncommon

Cultured meat manufacturer.

37
$30M · Series A Balderton Capital, Lowercarbon Capital 11 to 50 Climate Tech & Green Tech, Foodtech Cambridge, UK •••••••••••@uncommonbio.co
Zetta Genomics

Genomic data analysis platform.

37
$2M · Seed We Venture Capital, Nina Capital, LinkedIn 11 to 50 Biotech, Data and Analytics B2B, SaaS Cambridge, UK •••••••••••@zettagenomics.com
Nu Quantum

Nu Quantum is a telecommunications company that develops end-to-end quantum cryptography systems.

37
$7M · Seed Expeditions Fund, Amadeus Capital, IQ Capital Partners 1 to 10 Hardware, Cybersecurity, Manufacturing, Communications B2B Cambridge, UK •••••••••••@nu-quantum.com
Healx

Healx is an AI-powered, patient-inspired technology company, pioneering the next generation of drug discovery for rare diseases.

37
$56M · Series B Balderton Capital, Atomico, Amadeus Capital 51 to 100 Health Tech, AI, Biotech, Pharma, Data and Analytics, Business Intelligence B2B, SaaS Cambridge, UK •••••••••••@healx.io
Devo

Devo is a cybersecurity company that provides cloud-native logging and security analytics for organizations.

37
$100M Bessemer Venture Partners, Kibo Ventures, Insight Venture Partners 251 to 500 Cybersecurity, Data and Analytics, Privacy and Security, Business Intelligence, Developer Tools, Cloud B2B, SaaS Cambridge, UK •••••••••••@devo.com
Secondmind

Machine learning for automotive innovators

37
$16M · Series A Amadeus Capital, Mazda Motor Corporation, Cambridge Innovation Capital 51 to 100 AI Cambridge, UK •••••••••••@secondmind.ai
Endomag

Endomag is a medical technology company devoted to improving breast cancer care through its magnetic sensing technologies.

31
$20M · Series D Molten Ventures 51 to 100 Health Tech, Hardware B2B Cambridge, UK •••••••••••@endomag.com
Mosaic Therapeutics

Anti-cancer drug developer.

31
$28M · Series A Syncona Partners LLP, Cambridge Innovation Capital 101 to 250 Biotech Cambridge, UK •••••••••••@mosaic-tx.com
Supplant

Supplant is a biotechnology platform that makes sugar substitutes.

31
$24M Khosla Ventures, Felicis Ventures, Y Combinator 11 to 50 Health Tech, Foodtech, Deep Tech, Manufacturing B2B Cambridge, UK •••••••••••@supplant.com
bit.bio

Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell.

31
$41M · Series A Metaplanet Holdings, BlueYard Capital 101 to 250 Health Tech, Biotech, Deep Tech, Business Intelligence B2B Cambridge, UK •••••••••••@bit.bio
Mogrify

Mogrify® will transform the development of ex vivo cell therapies and pioneer a new class of in vivo reprogramming therapies.

31
$10M · Series A Astellas Venture Management, Ahren Innovation Capital, Parkwalk Advisors 101 to 250 Health Tech, Biotech, Deep Tech B2B Cambridge, UK •••••••••••@mogrify.co.uk
Broken String Biosciences

Genomics company building safer cell and gene therapies.

31
$15M · Series A Tencent, Illumina Ventures 1 to 10 Health Tech, Biotech Cambridge, UK •••••••••••@brokenstringbio.com
Metrion Biosciences

Metrion Biosciences is a Contract Research Organization.

31
$4M · Series A Gresham House Ventures, NPIF Maven Equity Finance 11 to 50 Health Tech, Deep Tech Cambridge, UK •••••••••••@metrionbiosciences.com
evonetix

DNA synthesis technology researcher.

31
$24M · Series B Foresite Capital 11 to 50 Biotech Cambridge, UK •••••••••••@evonetix.com
Unitary

AI-driven visual content moderation platform.

31
$15M · Series A January Ventures, Creandum, Plural 11 to 50 AI, Sales and Marketing B2B, SaaS Cambridge, UK •••••••••••@unitary.ai
Risilience

Climate analytics and risk assessement.

31
$26M · Series B IQ Capital Partners 11 to 50 Data and Analytics, Business Intelligence B2B, SaaS Cambridge, UK •••••••••••@risilience.com
Riverlane

OS for quantum computers.

31
$18M · Series B Molten Ventures, Amadeus Capital, Cambridge Innovation Capital 11 to 50 B2B Cambridge, UK •••••••••••@riverlane.com
TidalSense

AI-driven tech for respiratory conditions.

31
$9M · Series A Business Growth Fund, Downing Ventures 11 to 50 Health Tech, AI Cambridge, UK •••••••••••@tidalsense.com
Cyted

Cancer diagnostics.

31
$16M · Series A Business Growth Fund 51 to 100 Health Tech, Deep Tech Cambridge, UK •••••••••••@cyted.ai
Nuclera

Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis.

31
$42M · Series B Future Planet Capital, Amadeus Capital, Verve Ventures 11 to 50 Biotech, Deep Tech, Manufacturing B2B Cambridge, UK •••••••••••@nuclera.com
Eagle Genomics

Eagle Genomics is a enterprise software solutions company to enable the management, orchestration and exploitation of life sciences data.

26
$3M · Seed ETF Partners, Granpool Innovative Investments 11 to 50 Health Tech, Biotech B2B Cambridge, UK •••••••••••@eaglegenomics.com
Epitopea

Epitopea is a transatlantic cancer immunotherapeutics company.

26
$13M · Seed Cambridge Innovation Capital 1 to 10 Health Tech, Biotech, Deep Tech, Pharma B2B Cambridge, UK •••••••••••@epitopea.com
MISSION Therapeutics

Deubiquitylating enzyme (DUB) drug discovery and development platform.

26
$6M · Series A Sofinnova Partners, Rosetta Capital, Pfizer Venture Investments 51 to 100 Health Tech, Biotech Cambridge, UK •••••••••••@missiontherapeutics.com
Speechmatics

Speechmatics is a software company that provides automous speech and voice recognition technology for live and pre-recorded media.

26
$8M · Series A AlbionVC, IQ Capital Partners 101 to 250 Music and Audio, Data and Analytics, Business Intelligence B2B, SaaS Cambridge, UK •••••••••••@speechmatics.com
Abzena

Drug manufacturer.

26
$10M · Series A Biospring Partners 501 to 1000 Health Tech, Biotech, Pharma B2B, SaaS Cambridge, UK •••••••••••@abzena.com
Cake

Cake is the world's largest platform for helping people navigate end-of-life.

26
$14M Creandum, Headline 1 to 10 Health Tech, Mobile, Mobility & Transportation, Manufacturing, Sales and Marketing B2C Cambridge, UK •••••••••••@joincake.com
Flusso

Flusso is in stealth mode, while developing the world's smallest flow sensor.

26
$5M · Series A Parkwalk Advisors, Martlet Capital 11 to 50 Navigation and Mapping, Manufacturing B2B Cambridge, UK •••••••••••@flussoltd.com
Agile Analog

Supplier of configurable process node agnostic analog IP building blocks.

26
$5M · Seed Omers Ventures, Firstminute Capital, MMC Ventures 11 to 50 Deep Tech, Manufacturing, Semiconductor B2B Cambridge, UK •••••••••••@agileanalog.com
Cydar Medical

Precision software for surgeries.

26
$11M · Series A Pembroke VCT 11 to 50 Health Tech B2B, SaaS Cambridge, UK •••••••••••@cydarmedical.com
Qkine

Manufacturer of growth factor proteins for stem cell, organoid and cellular agriculture applications.

26
$5M · Series B Parkwalk Advisors, Downing Ventures 11 to 50 Biotech, Deep Tech Cambridge, UK •••••••••••@qkine.com
Axol Bioscience

Axol Bioscience sells live human cell cultures and provides services such as genome editing to researchers.

26
$5M Calculus Capital 11 to 50 Health Tech, Biotech, Pharma, Business Intelligence B2B Cambridge, UK •••••••••••@axolbio.com
PetMedix

PetMedix is a pet therapeutics startup.

26
$13M · Series A Cambridge Innovation Capital, Parkwalk Advisors 1 to 10 Health Tech, Biotech, Deep Tech, Pharma B2B Cambridge, UK •••••••••••@petmedix.co.uk
Signaloid

Cloud-based computing platform.

26
$3M · Seed IQ Capital Partners, Creator Fund 11 to 50 Hardware, Manufacturing B2B Cambridge, UK •••••••••••@signaloid.ai
PillSorted

PillSorted is a Pharmacy, blending compassionate care and innovative technology to deliver a truly Personal Pharmacy service.

26
$6M · Seed Hoxton Ventures 11 to 50 Health Tech, CPG & Consumer Goods, Pharma, Ecommerce B2B, B2C, SaaS Cambridge, UK •••••••••••@pillsorted.com
Forefront RF

Semiconductor developer.

26
$8M · Series A Business Growth Fund 11 to 50 Hardware, Manufacturing, Semiconductor B2B Cambridge, UK •••••••••••@forefrontrf.com
Nyobolt

Nyobolt is a developer of high-powered battery technology used to serve automotive applications.

26
$10M · Series A IQ Capital Partners 11 to 50 Climate Tech & Green Tech, Energy & Nuclear, Manufacturing B2B Cambridge, UK •••••••••••@nyobolt.com
Cambridge GaN Devices

Cambridge GaN Devices develops transistors designed to bring widespread adoption of GaN technology in consumer electronics.

26
$19M IQ Capital Partners, Cambridge Innovation Capital, Business Growth Fund 11 to 50 Manufacturing B2B Cambridge, UK •••••••••••@camgandevices.com
Pivotal

Biodiversity measurement platform.

26
$5M · Seed Octopus Ventures 11 to 50 Climate Tech & Green Tech Cambridge, UK •••••••••••@pivotal.earth
GeoSpock

GeoSpock builds GeoSpock DB, the unique space-time analytics database that delivers rapid insights at a fraction of the cost.

26
$5M Parkwalk Advisors 11 to 50 Climate Tech & Green Tech, Fintech, Mobile, Data and Analytics, Business Intelligence, Internet of Things, Developer Tools, Cloud B2B, SaaS Cambridge, UK •••••••••••@geospock.com
Mestag Therapeutics

Mestag Therapeutics is a biotechnology company that develops new therapies for diseases using fibroblast technology.

26
$11M · Seed GV, Forbion Capital Partners 1 to 10 Health Tech, Biotech, Deep Tech, Manufacturing B2B Cambridge, UK •••••••••••@mestagtx.com
Foundries.io

Foundries.io delivers secure, over-the-air updatable software platforms for embedded product development.

26
$8M · Series A BACKED VC, Crane Venture Partners, IQ Capital Partners 11 to 50 B2B, SaaS Cambridge, UK •••••••••••@foundries.io
Gearset

Setting the standard for Salesforce DevOps

23
$55M 101 to 250 Sales and Marketing, Developer Tools B2B, SaaS Cambridge, UK •••••••••••@gearset.com
Cambridge Epigenetix

Cambridge Epigenetix is using epigenetics to reduce several routine & important diagnostic tests for common cancers to a simple blood draw.

23
$88M · Series D 51 to 100 Health Tech, Deep Tech Cambridge, UK •••••••••••@cambridge-epigenetix.com
Artios Pharma

Artios Pharma is a independent DNA Damage Response company with a strong pipeline of novel cancer therapies.

23
$152M · Series C 101 to 250 Health Tech, Deep Tech Cambridge, UK •••••••••••@artiospharma.com
Owlstone Medical

Owlstone Medical is a diagnostics company that developed a non-invasive breathalyzer for infectious disease detection.

23
$57M · Series D 101 to 250 Health Tech Cambridge, UK •••••••••••@owlstonemedical.com
Fieldwork Robotics

Manufacturer of autonomous harvesting robots.

21
$1M · Seed Elbow Beach Capital 1 to 10 Robotics, Manufacturing B2B Cambridge, UK •••••••••••@fieldworkrobotics.com
World Makers

Social multi-player gaming studio.

21
$4M · Series A Makers Fund 1 to 10 Foodtech, Gaming, CPG & Consumer Goods, Consumer Social, Community & Lifestyle B2C Cambridge, UK •••••••••••@worldmakers.com
Xampla

Plant-based biodegradable material producer.

21
$2M · Seed Amadeus Capital, Horizons Ventures, Parkwalk Advisors 1 to 10 Biotech B2B Cambridge, UK •••••••••••@xampla.com
Sphere Fluidics

Sphere Fluidics develops products for use in single cell analysis and characterization, and provides associated collaborative R&D services.

21
$4M Sofinnova Partners 11 to 50 Health Tech, Deep Tech B2B Cambridge, UK •••••••••••@spherefluidics.com
techspert

Techspert is an AI-driven technology for identifying and sourcing specialist expertise, globally.

21
$4M · Series A Nauta Capital, Business Growth Fund 51 to 100 AI, Business Intelligence B2B, SaaS, Marketplace Cambridge, UK •••••••••••@techspert.com
HexagonFab

HexagonFab is the biological sensor for rapid and cost-effective detection of biological substances.

21
$2M · Seed Parkwalk Advisors 1 to 10 Hardware, Biotech, Manufacturing, Business Intelligence B2B Cambridge, UK •••••••••••@hexagonfab.com
Luminance HIRING

Generative AI platform for law firms.

21
$3M · Seed Talis Capital, National Grid Partners (NGP), March Capital 101 to 250 AI, Legal Tech B2B, SaaS Cambridge, UK •••••••••••@luminance.com
Semarion

Semarion leverages microfabrication technology to build smart materials and develop novel cell assaying applications.

21
$2M · Seed Parkwalk Advisors, Martlet Capital 1 to 10 Health Tech, Biotech, Manufacturing B2B Cambridge, UK •••••••••••@semarion.com
KisanHub

KisanHub Agri-Food Supply Chain Software helps Producer Groups to transform their supply chains

21
$4M · Series A Notion Capital, IQ Capital Partners 11 to 50 Climate Tech & Green Tech, Agritech B2B, SaaS Cambridge, UK •••••••••••@kisanhub.com
Fetch.ai

Decentralized network.

20
$40M · Series B 11 to 50 Crypto & web3 B2B, SaaS Cambridge, UK •••••••••••@fetch.ai
Storm Therapeutics

Novel cancer therapies.

20
$30M · Series B 11 to 50 Health Tech, Deep Tech B2C Cambridge, UK •••••••••••@stormtherapeutics.com
Cambridge Quantum Computing

CQCL develops tools for the commercialisation of quantum computers by understanding quantum protocols and also quantum algorithms.

20
$45M 101 to 250 Hardware, AI, Manufacturing, Enterprise Software, Quantum Computing B2B Cambridge, UK •••••••••••@cambridgequantum.com
DataQube Global

DataQube is the developer of 5G enabled edge data centre.

20
$29M · Series A 11 to 50 Cambridge, UK •••••••••••@dataqube.global
PhoreMost

PhoreMost is a new-model drug discovery company based in Cambridge, UK.

20
$45M · Series B 1 to 10 Health Tech, Deep Tech Cambridge, UK •••••••••••@phoremost.com
Biofidelity HIRING

Genomic technology developer to detect biomarkers for non-small cell lung cancer (NSCLC).

17
$940k · Seed Octopus Ventures, Longwall Venture, BlueYard Capital 11 to 50 Health Tech, Biotech B2B Cambridge, UK •••••••••••@biofidelity.com
OTHER CITIES
OTHER CITIES IN UK